Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    Open Studies | "Anemia, Aplastic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anemia, Aplastic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide,Campath IH and TBI
2 Recruiting Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
Condition: Anemia, Aplastic
Interventions: Drug: Eltrombopag;   Drug: Placebo (for Eltrombopag)
3 Not yet recruiting Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: rhTPO;   Drug: placebo
4 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
5 Recruiting Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Rabbit antithymoglobulin (ATG);   Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs);   Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs)
6 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
7 Recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
8 Recruiting The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Procedure: IST;   Biological: cord blood transfusion;   Drug: Thymoglobuline® and oral CSA
9 Not yet recruiting Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Condition: Severe Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
10 Recruiting A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: rabbit ATG, Cyclosporine, Levamisole
11 Not yet recruiting ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Rabbit ATG, (Genzyme);   Drug: Cy;   Drug: CsA;   Biological: Cord blood
12 Recruiting Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: cyclosporine;   Procedure: Matched Unrelated Donor Hematopoietic Stem Cell Transplant;   Drug: horse anti-thymocyte globulin (ATG);   Drug: rabbit anti-thymocyte globulin (ATG);   Drug: methotrexate;   Drug: fludarabine;   Drug: cyclophosphamide;   Radiation: low-dose total body irradiation (TBI);   Procedure: Immunosuppressive Therapy (IST)
13 Recruiting Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Rabbit ATG
14 Recruiting Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia (SAA)
Intervention: Drug: Eltrombopag
15 Recruiting Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Conditions: Dyskeratosis Congenita;   Aplastic Anemia
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
16 Recruiting Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Condition: Severe Aplastic Anemia
Intervention: Drug: Sirolimus
17 Recruiting hATG+CsA vs hATG+CsA+Eltrombopag for SAA
Condition: Severe Aplastic Anemia
Interventions: Drug: hATG;   Drug: CsA;   Drug: Eltrombopag
18 Recruiting Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA
Condition: Acquired Aplastic Anemia.
Intervention: Drug: Thymoglobulin
19 Recruiting Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Conditions: Aplastic Anemia;   Hypoplastic Myelodysplastic Syndrome
Interventions: Drug: BL-8040;   Drug: horse anti-thymocyte globulin (hATG);   Drug: Methylprednisolone;   Drug: Cyclosporine
20 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.